Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients

Detalles Bibliográficos
Autores principales: Lee, Meng, Chen, Chi-Hsin Sally, Ovbiagele, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202820/
https://www.ncbi.nlm.nih.gov/pubmed/32413768
http://dx.doi.org/10.1016/j.jns.2020.116883
_version_ 1783529768290877440
author Lee, Meng
Chen, Chi-Hsin Sally
Ovbiagele, Bruce
author_facet Lee, Meng
Chen, Chi-Hsin Sally
Ovbiagele, Bruce
author_sort Lee, Meng
collection PubMed
description
format Online
Article
Text
id pubmed-7202820
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-72028202020-05-07 Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients Lee, Meng Chen, Chi-Hsin Sally Ovbiagele, Bruce J Neurol Sci Letter to the Editor Elsevier B.V. 2020-07-15 2020-05-06 /pmc/articles/PMC7202820/ /pubmed/32413768 http://dx.doi.org/10.1016/j.jns.2020.116883 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Lee, Meng
Chen, Chi-Hsin Sally
Ovbiagele, Bruce
Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients
title Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients
title_full Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients
title_fullStr Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients
title_full_unstemmed Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients
title_short Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients
title_sort covert covid-19 complications: continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202820/
https://www.ncbi.nlm.nih.gov/pubmed/32413768
http://dx.doi.org/10.1016/j.jns.2020.116883
work_keys_str_mv AT leemeng covertcovid19complicationscontinuingtheuseofevidencebaseddrugstominimizepotentiallylethalindirecteffectsofthepandemicinstrokepatients
AT chenchihsinsally covertcovid19complicationscontinuingtheuseofevidencebaseddrugstominimizepotentiallylethalindirecteffectsofthepandemicinstrokepatients
AT ovbiagelebruce covertcovid19complicationscontinuingtheuseofevidencebaseddrugstominimizepotentiallylethalindirecteffectsofthepandemicinstrokepatients

Ejemplares similares